A new study has found GLP-1s may reduce the risk of developing obesity-related cancers by 41% compared to bariatric surgery — a benefit researchers believe could be tied to the drugs’ ability to ...

Queen Latifah opens up about obesity and heart health risks for public awareness campaign, Truth About Weight.

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

"Protein has been shown to boost GLP-1 levels which helps appetite control. Good options for snacks include boiled eggs, ...

From canola oil to colorful dyes, the US food industry is girding for a shift away from the ingredients that made American diets among the cheapest in the world. Health Secretary Robert F. Kennedy Jr.

Q1 2025 Earnings Call Transcript May 14, 2025 Allurion Technologies Inc. beats earnings expectations. Reported EPS is $0.43, expectations were $-1.53. Operator: Hello, everyone, and welcome to ...

The prevalence of obesity among young people in the UK represents a significant challenge within the field of public health.

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

A new study shows that people who develop type 1 diabetes in adulthood have an increased risk of cardiovascular disease and death, and that those diagnosed later in life do not have a better prognosis ...

Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...

A new nationwide analysis is shedding light on how states compare when it comes to a major public health challenge, and the ...